PR Newswire
BRAINTREE, Mass., Dec. 20, 2018
BRAINTREE, Mass., Dec. 20, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019 at 3:30pm Pacific time / 6:30pm Eastern time.
The public may access Mr. Simon's presentation live via webcast at: https://jpmorgan.metameetings.net/events/healthcare19/sessions/23877-haemonetics-corporation/webcast
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit http://www.haemonetics.com.
INVESTOR CONTACTS: | MEDIA CONTACT: |
Gerry Gould, VP-Investor Relations | Carla Burigatto, VP-Communications |
(781) 356-9402 | (781) 348-7263 |
Olga Vlasova, Sr. Mgr.-Investor Relations | |
(781) 356-9763 | |
View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-37th-annual-jp-morgan-healthcare-conference-300769142.html
SOURCE Haemonetics Corporation
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member